Globus Medical, Inc.
GMED
$71.04
$1.361.95%
GMED market cap represents
0.36%
of the industry.
Valuation
GMED
Low
GMED
Industry Average
High
Market Cap
9.58B
< 5.17B
> 20.68B
Enterprise Value
9.17B
< 6.25B
> 25.01B
Price/Earnings (TTM)
93.23
< 0.00
> 100.00
Earnings Per Share Growth (TTM)
-35.72%
< -40.00%
> 220.00%
Price/Earnings To Growth (TTM)
--
0.01
9.36
Price/Sales (TTM)
3.86
< 0.000
> 30.00
Price/Book (Q)
2.29
< 0.00
> 10.00
Enterprise Value/Revenue (TTM)
3.64
< 0.00
> 30.00
Enterprise Value/EBITDA (TTM)
13.28
< -70.00
> 20.00
Enterprise Value/EBIT (TTM)
21.01
< -10.00
> 30.00
Dividends and Shares
GMED
Low
GMED
Industry Average
High
Shares Outstanding
139.71M
< 50.00M
> 240.00M
Dividend Per Share (Most Recent)
--
0.03
2.10
Dividend Per Share (TTM)
--
0.06
8.40
Dividend Yield (TTM)
--
0.15%
7.71%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
GMED
Low
GMED
Industry Average
High
Beta
1.33
< 0.00
4.08
1-Month Total Return
-16.98%
< -30.00%
> 0.00%
3-Month Total Return
-14.71%
< -20.00%
> 0.00%
6-Month Total Return
-0.41%
< -10.00%
> 20.00%
Year to Date Total Return
-14.85%
< -20.00%
> 0.00%
1-Year Total Return
34.34%
< 0.00%
> 40.00%
2-Year Total Return
32.27%
< 0.00%
> 40.00%
3-Year Total Return
8.13%
< -10.00%
> 10.00%
5-Year Total Return
98.75%
< 90.00%
> 370.00%
Profitability
GMED
Low
GMED
Industry Average
High
Operating Margin (TTM)
17.31%
< -1,350.00%
> 20.00%
Profit Margin (TTM)
4.08%
< -1,270.00%
> 10.00%
Management Effectiveness
GMED
Low
GMED
Industry Average
High
Return on Assets (TTM)
5.27%
< -20.00%
> 10.00%
Return on Equity (TTM)
2.52%
0.36%
> 50.00%
Income Statement
GMED
Low
GMED
Industry Average
High
Revenue (TTM)
2.52B
< 2.51B
> 24.32B
Total Revenue (TTM)
2.52B
< 2.51B
> 24.88B
Total Revenue Growth (Q YOY)
6.61%
< 0.00%
> 1,190.00%
Revenue Per Share (TTM)
18.03
< 10.00
> 150.00
Gross Profit (TTM)
1.70B
< 1.20B
> 4.81B
EBITDA (TTM)
690.20M
< 430.00M
> 1.73B
EBIT (TTM)
436.18M
< 310.00M
> 1.27B
Net Income (TTM)
102.98M
< 100.00M
> 670.00M
Net Income Avl. to Common (TTM)
102.98M
< 100.00M
> 670.00M
Earnings Growth (Q YOY)
76.30%
< -790.00%
> 80.00%
EPS Diluted (TTM)
0.75
< -20.00
> 10.00
EPS Diluted Growth (Q YOY)
82.87%
< -310.00%
> 90.00%
Balance Sheet
GMED
Low
GMED
Industry Average
High
Cash and Short-Term Inv. (Q)
890.06M
< 450.00M
> 1.82B
Cash Per Share (Q)
6.37
0.01
> 30.00
Total Current Assets (Q)
2.18B
< 1.50B
> 6.02B
Total Assets (Q)
5.25B
< 4.23B
> 16.94B
Total Current Liabilities (Q)
855.91M
< 850.00M
> 5.26B
Total Debt (Q)
537.72M
< 530.00M
> 5.13B
Total Liabilities (Q)
1.07B
< 1.07B
> 11.05B
Total Common Equity (Q)
4.18B
< 1.40B
> 5.64B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
4.18B
< 1.47B
> 5.89B
Current Ratio (Q)
2.544
0.009
> 10.000
Book Value Per Share (Q)
30.40
< 0.00
> 40.00
Cash Flow
GMED
Low
GMED
Industry Average
High
Cash from Operations (TTM)
520.64M
< 270.00M
> 1.12B
Cash from Investing (TTM)
-176.05M
< -760.00M
> -170.00M
Cash from Financing (TTM)
-27.70M
< -350.00M
> -20.00M
Net Change in Cash (TTM)
317.15M
< 0.00
> 320.00M
Levered Free Cash Flow (TTM)
594.83M
< 160.00M
> 670.00M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
